Clinical Statistics
We offer pharmaceutical, biotech, medical device companies or contract research organisations the opportunity to take advantage of our statistical expertise. Read more
Pharmacokinetics/-dynamics
Pharmacokinetics and -dynamics play a crucial role in early clinical development. We analyse these data with WinNonlin and SAS software. Read more
Translational Medicine & Biomarkers
The translational medicine approach is indispensable for future drug development. We offer support with our experienced staff in that field. Read more
Health Technology Assessment (HTA)
Staburo provides dossier support for submission to HTA authorities, such as IQWiG or NICE. Read more
Statistical Programming with CDISC
We provide statistical programming with SAS and R for clinical projects, including ADaM and SDTM standards for submissions. Read more
Non-clinical Statistics
Staburo offers statistics for medical device companies and non-clinical projects that require statistical support. Read more
Data analysis, clinical biostatistics and more.
Company founded in
Employees
Percent employees with university degree
Projects
Solutions
Consulting
Staburo supports clients in all biostatistics and statistical programming questions and helps to find solutions. Read more
Outsourcing
We cover a wide range of statistical services and manage entire biostatistics projects for our clients on a flexible basis. Read more
Insourcing
Staburo biostatisticians support R&D departments in case of work peaks or if external expertise is needed. Read more
Beyond Biostatistics
Our team members are experts in biostatistics. Beyond that, we are experienced in project work, working on different infrastructures and with complex processes.
Communication
You will have a single point of contact for your biostatistics needs. A personal on-site contact is often the start for a long and efficient collaboration. Read more
Project Experience
We are used to working on different IT infrastructures. Additionally, we have knowledge of terminology and key processes in interdisciplinary and/or international teams. Read more
Staburo Client Segments
- Pharma
- CROs
- Biotech, Medical Device companies, etc.
Why Staburo?
Biostatistics experts
Temporally and spatially flexible
Experienced in pharma processes
Check out our latest news!
Post event: Anything new for oncology?
Post event: Anything new for oncology? Lately, Basel Biometric Section and EFSPI organized a webinar "Estimands addendum is final: Anything new for oncology?". You can find the program, the slides, a recording of the entire event, and a document that answers questions...
Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology?
Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology? We are very proud that Staburo's Managing Director Dr. Hannes Buchner will be a speaker and will talk about "Treatment switching: challenges, estimands, and estimators". All...
How to Avoid Overfitting, Precision Medicine in Action & Tumour Growth Modelling – three PSI contributions
Staburo's 2020 PSI contributions in webinar format on 26 May (15:00 – 17:15 CET) Since the 2020 PSI conference will unfortunately not take place, we decided to share our PSI contributions in an online live webinar with our colleagues. Staburo biostatisticians Nicole...